1. Home
  2. 🏥 Medical
  3. PR Vademécum Argentina 2026
PR Vademécum Argentina 2026

PR Vademécum Argentina 2026

by Clyna S.A.

0 ratings
3 reviews
💪 Health & Fitness
🏥 Medical
$19.99

Details

  • Released
  • Updated
  • February 6, 2019
  • June 19, 2026

Features

Developer

Clyna S.A.
✨Promote your app ✨
PR Vademécum Argentina 2026 screenshot #1 for iPhone
PR Vademécum Argentina 2026 screenshot #2 for iPhone
PR Vademécum Argentina 2026 screenshot #3 for iPhone
iphone
ipad
⭐3
Reviews↘︎
🔄3+ apps
Alternatives↘︎
❓8 answered
FAQ↘︎
📦~ in 2 months
Updates frequency↘︎
🖼️Get Icon
Icons↘︎

About

Access up-to-date information on prescription medications and drugs marketed in Argentina. This app provides detailed prospectuses, laboratory listings, pathology indications, and drug interaction data.

✓Updated medication information
✓Prescription drug details
✓Product prospectuses
✓Laboratory and product listings
✓Pathology and drug indications
✓Drug interaction data
✓Pharmacological and therapeutic indexes
Show original description

What's New in PR Vademécum Argentina 2026

8.1.3

June 19, 2026

Novedades en el aplicativo: AXIV TOSTOP NIÑOS CADOS EXCELLENCE CISPLATINO IMA DERMICOL TRIO DUNLEY ERIPAL FLEPAX GADO-TEC HEADON 50 LUTRATE 22,5 LUTRATE 3,75 MOLAPIB NEDAL S PRAVOX TANZAL VALCATIL CAFEINA

More

User reviews

Most RecentHighest RatedLowest Rated

Recomendable

Es práctico, útil, se encuentra lo que se busca. Tiene un precio accesible para Argentina. Si falta algo, para eso tenemos libros pertinentes.
iPad de orlandoiPad de orlando

La aplicación no funciona

Solo puedo ingresar productos, no nombre genérico de la droga , cuando quiero utilizar el indice o ir para atrás no responde
cecivcmcecivcm

Recomendable

Para mi gusto le da demasiada importancia a los nombres comerciales, por lo que se dificulta a la hora de ver presentaciones, asociaciones y demás de un farmaco. Igualmente la info está. Es buena y recomendable!
RodcortsRodcorts

Developer apps

PR Vademécum Chile 2026
PR Vademécum Chile 2026

by Clyna S.A.

🏥 Medical
$19.99
PR Vademécum Perú 2026
PR Vademécum Perú 2026

by Clyna S.A.

🏥 Medical
$19.99
PR Vade-mécum Brasil 2026
PR Vade-mécum Brasil 2026

by Clyna S.A.

🏥 Medical
$19.99
See developer apps

FAQ

What is PR Vademécum Argentina 2026?

PR Vademécum Argentina 2026 is a mobile application that provides updated information on prescription medications and drugs marketed in Argentina. It includes details on products, laboratories, pathologies, and drug interactions.

Where does PR Vademécum Argentina 2026 get its information?

The app's information is developed from reliable sources, including drug manufacturers and current medical-pharmacological literature. It aims to provide accurate and up-to-date data for its users.

What types of information can I find in PR Vademécum Argentina 2026?

You can find product prospectuses, lists of laboratories and their products, indications for specific pathologies, drug interactions, pharmacological actions of active ingredients, therapeutic actions, and related substances.

Is PR Vademécum Argentina 2026 available on Android devices?

Based on the provided data, PR Vademécum Argentina 2026 is supported on iPhone, iPad, and iPod. Information regarding Android compatibility is not specified.

How often is PR Vademécum Argentina 2026 updated?

The latest version of PR Vademécum Argentina 2026 is 8.1.3, and it was last updated on June 19, 2026. This indicates a commitment to providing current information.

What is the price of PR Vademécum Argentina 2026?

PR Vademécum Argentina 2026 is a paid application with a price of $19.99. This one-time purchase grants access to its comprehensive drug information.

What is the age rating for PR Vademécum Argentina 2026?

PR Vademécum Argentina 2026 has an age rating of 17+. This suggests that the content is intended for mature audiences due to the nature of medical information.

Does PR Vademécum Argentina 2026 contain advertisements?

No, PR Vademécum Argentina 2026 does not contain advertisements. The application is a paid product, ensuring an ad-free experience for users.